A-shares movement丨Shareholders plan to reduce their holdings, Shanwaishan falls 5.4%, Market Cap barely holds at 4 billion yuan.

On May 8, according to Gelonghui, Shanfangshan (688410.SH) closed down 5.4% to 12.7 yuan at noon, with a market capitalization barely holding above 4 billion yuan. In news, the company announced last night that Shareholder Hunan Xiangjiang Liyuan Investment Management Co., Ltd. - Hunan Xiangjiang Liyuan Jian Kun Venture Capital Partnership (Limited Partnership), and Hunan Xiangjiang Liyuan Investment Management Co., Ltd. - Hunan Xiangjiang Health Venture Capital Partnership (Limited Partnership) plan to reduce their shareholding in the company by no more than 12.8526 million shares, which is no more than 4% of the company's total share capital. In addition, it is noted that the company has published shareholding reduction plan announcements 5 times in the past three years.

Gelonghui FinanceMay 8 11:37

Express News | Mountain Outside Mountain: Shareholders Da Health and Li Yuan Jian Kun plan to reduce their shareholding by no more than 4% of the company's shares.

BreakingsMay 7 21:29

Shanwaishan (688410.SH): has not been involved in the manufacturing of deionized water equipment related to Integrated Circuits PCB and other businesses.

On April 30, Glonghui stated on the interactive platform that Shanwaishan (688410.SH) is a national high-tech enterprise that integrates blood purification equipment, blood purification consumables, intelligent management systems for blood purification centers, and chain dialysis centers. It provides comprehensive blood purification solutions for Global kidney disease and critically ill patients, focusing on the blood purification segment of medical instruments. Currently, the company has not engaged in Business related to the manufacturing of deionized water equipment like Integrated Circuits PCBs.

Gelonghui FinanceApr 30 15:45

Shanwai Mountain (688410.SH): The DeepSeek large model has not yet been deployed locally.

On April 30, Gelonghui reported that Shanwaishan (688410.SH) stated on the interactive platform that the company has not yet locally deployed the DeepSeek large model. Currently, the company encourages employees to learn and use DeepSeek through public channels to improve work efficiency. The company will continue to focus on the development of AI large model technologies like DeepSeek and actively explore diverse cooperation opportunities.

Gelonghui FinanceApr 30 15:44

Direct coverage of the Star medical instruments industry collective Earnings Conference: Multiple companies are laying out AI medical Business, and key segments in innovation fields may accelerate the development of domestic production.

① Attending companies believe that tariff policies will bring some cost pressures and market challenges to enterprises, but at the same time, it has accelerated the localization process in relevant fields; ② Some attending companies disclosed the latest developments in their Business during the earnings briefing and the planning for related lines by 2025.

cls.cnApr 26 13:45

Express News | Star closing review: The Innovative Drugs and medical instruments sectors were active, while the Software sector showed mixed results.

BreakingsApr 22 15:05